Announce Date | 02/26/2025 |
EPS Normalized Actual | $0.15 (Beat by $0.02) |
EPS GAAP Actual | $0.15 (Beat by $0.02) |
Revenue Actual | $0.100361B |
Revenue Surprise | Beat by $100.361M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.13461 |
EPS GAAP Estimate | $0.13461 |
Revenue Estimate | $0.107670806B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.9 | 10.61 | 0.88395 | 0.91482 | 1 |
Dec 2028 | 0.76 | 12.57 | 0.74644 | 0.77251 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.041 | 0.041 | 0.100361B | 12.31% | 100.36M |
FQ3 2024 (Sep 2024) | -0.0085 | -0.0085 | 0.09482B | 9.75% | 94.82M |
FQ1 2019 (Mar 2019) | 0 | 0 | 0.050584B | 100% | 50.58M |
FQ2 2019 (Jun 2019) | 0 | 0 | 0.050584B | 100% | 50.58M |
FQ3 2019 (Sep 2019) | 0 | 0 | 0.053486B | 100% | 53.49M |
FQ2 2024 (Jun 2024) | -0.0783 | -0.0783 | 0.093313B | 3.07% | 93.31M |
FQ1 2024 (Mar 2024) | -0.0294 | -0.0294 | 0.096654B | 6.57% | 96.65M |
FQ4 2023 (Dec 2023) | -0.0784 | -0.0784 | 0.08801B | 1.56% | 88.01M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.13461
Consensus Revenue Estimates
0.107670806B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.15699 | -- | 0.15204 | 0.16509 | 1 |
FQ2 2027 (Jun 2027) | 0.14279 | -- | 0.13829 | 0.15015 | 1 |
FQ1 2027 (Mar 2027) | 0.14727 | -- | 0.14263 | 0.15486 | 1 |
FQ4 2026 (Oct 2026) | 0.14417 | -- | 0.13914 | 0.15011 | 3 |
FQ3 2026 (Jul 2026) | 0.14579 | -- | 0.14071 | 0.1518 | 3 |
FQ2 2026 (Jun 2026) | 0.14927 | -- | 0.14282 | 0.15606 | 3 |
FQ1 2026 (Mar 2026) | 0.14931 | -- | 0.14286 | 0.1561 | 3 |
FQ4 2025 (Oct 2025) | 0.13445 | 69.51 | 0.12976 | 0.13999 | 3 |
FQ3 2025 (Jul 2025) | 0.12991 | 106.54 | 0.12538 | 0.13526 | 3 |
FQ2 2025 (Jun 2025) | 0.13461 | 158.17 | 0.1288 | 0.14073 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.13B | -- | 0.12B | 0.13B | 2 |
FQ2 2027 (Jun 2027) | 0.12B | -- | 0.12B | 0.13B | 2 |
FQ1 2027 (Mar 2027) | 0.13B | -- | 0.12B | 0.13B | 2 |
FQ4 2026 (Oct 2026) | 0.12B | -- | 0.12B | 0.12B | 4 |
FQ3 2026 (Jul 2026) | 0.12B | -- | 0.11B | 0.12B | 4 |
FQ2 2026 (Jun 2026) | 0.12B | -- | 0.11B | 0.12B | 2 |
FQ1 2026 (Mar 2026) | 0.12B | -- | 0.11B | 0.12B | 2 |
FQ4 2025 (Oct 2025) | 0.11B | 7.4 | 0.11B | 0.11B | 2 |
FQ3 2025 (Jul 2025) | 0.11B | 11.56 | 0.1B | 0.11B | 2 |
FQ2 2025 (Jun 2025) | 0.11B | 13.33 | 0.1B | 0.11B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
4
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.041 | 0.041 | 100% | |
FQ3 2024 (Sep 2024) | -0.0085 | -0.0085 | 100% | |
FQ1 2019 (Mar 2019) | 0 | 0 | NAN% | |
FQ2 2019 (Jun 2019) | 0 | 0 | NAN% | |
FQ3 2019 (Sep 2019) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | -0.0783 | -0.0783 | 100% | |
FQ1 2024 (Mar 2024) | -0.0294 | -0.0294 | 100% | |
FQ4 2023 (Dec 2023) | -0.0784 | -0.0784 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.1B | $100.36M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.09B | $94.82M | 100% |
FQ1 2019 (Mar 2019) | $0B | $0.05B | $50.58M | 100% |
FQ2 2019 (Jun 2019) | $0B | $0.05B | $50.58M | 100% |
FQ3 2019 (Sep 2019) | $0B | $0.05B | $53.49M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.09B | $93.31M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.1B | $96.65M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.09B | $88.01M | 100% |